翻訳と辞書
Words near each other
・ Ribosomal S15 leader
・ Ribosomal s6 kinase
・ Ribosomal translocation
・ Ribosomal-protein-alanine N-acetyltransferase
・ Ribosomally synthesized and post-translationally modified peptides
・ Ribosome
・ Ribosome biogenesis
・ Ribosome biogenesis protein BRX1 homolog
・ Ribosome display
・ Ribosome profiling
・ Ribosome Recycling Factor
・ Ribosome shunting
・ Ribosome-inactivating protein
・ Ribosome-nascent chain complex
・ Ribosomopathy
Ribostamycin
・ Riboswitch
・ Ribosyldihydronicotinamide dehydrogenase (quinone)
・ Ribosylnicotinamide kinase
・ Ribosylpyrimidine nucleosidase
・ Ribot
・ Ribot (horse)
・ Ribot's Law
・ Ribota
・ Ribotyping
・ Ribouisse
・ Riboux
・ Ribozyme
・ Ribozyme (band)
・ Ribs (band)


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Ribostamycin : ウィキペディア英語版
Ribostamycin

Ribostamycin is an aminoglycoside-aminocyclitol antibiotic isolated from a streptomycete, Streptomyces ribosidificus, originally identified in a soil sample from Tsu City of Mie Prefecture in Japan.〔Shomura, T.; Ezaki, N.; Tsuruoka, T.; Niwa, T.; Akita, E.; Niida, T.; Studies on Antibiotic SF-733, a New Antibiotic. I Taxonomy, Isolation and Characterization. The Journal of Antibiotics. 1970, 23 (3), 155-161.〕 It is made up of 3 ring subunits: 2-deoxystreptamine (DOS), neosamine C, and ribose.〔Subba, B.; Kharel, M.K.; Lee, H.C.; Liou, K.; Kim, B.G; Sohng, J.K.; The Ribostamycin Biosynthetic Gene Cluster in Streptomyces ribosidificus: Comparison With Butirosin Biosynthesis. Molecules and Cells. 2005, 20 (1), 90-96.〕 Ribostamycin, along with other aminoglycosides with the DOS subunit, is an important broad-spectrum antibiotic with important use against human immunodeficiency virus and is considered a critically important antimicrobial by the World Health Organization.,〔Kurumbang N.P.; Liou, K.; Sohng, J.K.; Biosynthesis of Ribostamycin Derivatives by Reconstitution and Heterologous Expression of Required Gene Sets. Applied Biochemistry and Biotechnology. 2011, 163, 373-382.〕〔World Health Organization. Critically Important Antimicrobials for Human Medicine 3rd revision. 2011〕 Resistance against aminoglycoside antibiotics, such as ribostamycin, is a growing concern. The resistant bacteria contain enzymes that modify the structure through phosphorylation, adenylation, and acetylation and prevent the antibiotic from being able to interact with the bacterial ribosomal RNAs.〔Kudo, F.; Eguchi, T.; Biosynthetic Genes for Aminoglycoside Antibiotics. The Journal of Antibiotics. 2009, 62, 471-481.〕
== Biosynthesis ==

The biosynthesis of ribostamycin begins with the sugar, D-glucose, which is phosphorylated at the 6 position to form glucose-6-phosphate. Enzyme rbmA contains a genetic sequence that corresponds to NAD+ binding and catalyzes the formation of 2-deoxy-scyllo-inosose. Enzyme rmbB then catalyzes the transamination of 2-deoxy-scyllo-inosose to 2-deoxy-scyllo-inosamine with L-glutamine and pyridoxal phosphate (PLP). Enzyme rbmC oxidizes the ring to 2-deoxy-3-amino-scyllo-inosose, which is then transaminated by enzyme rmbB to DOS. DOS is then glycosylated by the glycosyltransferase rmbD with uridine diphosphate N-acetylglucosamine (UDP-Glc-NAc) to form 2’-N-acetylparomamine. The deacetylase, racJ, removes the acetyl group and forms paromamine. Paromamine is oxidized by enzyme rbmG and then enzyme rmbH transaminates to produce neamine. Neamine is then ribosylated to form ribostamycin.,〔〔

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Ribostamycin」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.